Literature DB >> 12402251

A susceptibility gene for late-onset idiopathic Parkinson's disease.

Andrew A Hicks1, Hjörvar Pétursson, Thorlákur Jónsson, Hreinn Stefánsson, Hrefna S Jóhannsdóttir, Jesus Sainz, Michael L Frigge, Augustine Kong, Jeffrey R Gulcher, Kári Stefánsson, Sigurlaug Sveinbjörnsdóttir.   

Abstract

Eight regions of the genome (PARK1-8) have been implicated in autosomal dominant and autosomal recessive forms of early-onset Parkinson's disease. These forms constitute a few of all cases. However, except for a haplotype in six families (PARK3), no study has successfully mapped a gene or described mutations that contribute to the common late-onset Parkinson's disease. Some have even suggested that a genetic component does not exist. We cross-matched our nationwide genealogy database with a population-based list of Icelandic Parkinson's disease patients to search for families with more than one patient. We performed a genomewide scan on 117 patients and 168 of their unaffected relatives within 51 families using 781 microsatellite markers. Allele-sharing, model-independent analysis of the results showed linkage to a region on chromosome 1p32 with a logarithm of odds score of 3.9 (Z(lr) = 4.2). By increasing the information content with additional microsatellite markers in this region, we found that the logarithm of odds score increased to 4.9 (Z(lr) = 4.8). This result corresponds to an unadjusted p value of 1.0 x 10(-6) and p < 0.005 after adjusting for a genomewide search. We designate this region PARK10. We therefore have successfully mapped, to genomewide significance, a susceptibility gene for late-onset Parkinson's disease using multiple families drawn across a whole population. Identification of the susceptibility gene in this region may pave the way for a better understanding of the disease process, which, in turn, may lead to improved diagnostics and therapeutics.

Entities:  

Mesh:

Year:  2002        PMID: 12402251     DOI: 10.1002/ana.10324

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  75 in total

Review 1.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Current concepts in the diagnosis and management of Parkinson's disease.

Authors:  Mark Guttman; Stephen J Kish; Yoshiaki Furukawa
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

Review 3.  Prospects of genetic epidemiology in the 21st century.

Authors:  Marieke C J Dekker; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 4.  Fixing the broken system of genetic locus symbols: Parkinson disease and dystonia as examples.

Authors:  Connie Marras; Katja Lohmann; Anthony Lang; Christine Klein
Journal:  Neurology       Date:  2012-03-27       Impact factor: 9.910

5.  Familial risks of hospitalization for Parkinson's disease in first-degree relatives: a nationwide follow-up study from Sweden.

Authors:  Kristina Sundquist; Xinjun Li; Kari Hemminki
Journal:  Neurogenetics       Date:  2006-08-30       Impact factor: 2.660

6.  Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

Authors:  T Franck; R Krueger; D Woitalla; T Müller; S Engelender; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

7.  Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease.

Authors:  M Martinez; A Brice; J R Vaughan; A Zimprich; M M B Breteler; G Meco; A Filla; M J Farrer; C Bétard; J Hardy; G De Michele; V Bonifati; B Oostra; T Gasser; N W Wood; A Dürr
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

8.  Accommodating chromosome inversions in linkage analysis.

Authors:  Gary K Chen; Erin Slaten; Roel A Ophoff; Kenneth Lange
Journal:  Am J Hum Genet       Date:  2006-06-06       Impact factor: 11.025

9.  A case-control association study of the 12 single-nucleotide polymorphisms implicated in Parkinson disease by a recent genome scan.

Authors:  Yonghong Li; Charles Rowland; Steven Schrodi; Walter Laird; Kristina Tacey; David Ross; Diane Leong; Joseph Catanese; John Sninsky; Andrew Grupe
Journal:  Am J Hum Genet       Date:  2006-06       Impact factor: 11.025

10.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.